RT Journal Article
SR Electronic
T1 Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery
JF British Journal of Ophthalmology
JO Br J Ophthalmol
FD BMJ Publishing Group Ltd.
SP 1320
OP 1324
DO 10.1136/bjophthalmol-2014-304902
VO 98
IS 10
A1 Kiire, Christine A
A1 Mukherjee, Rajarshi
A1 Ruparelia, Neil
A1 Keeling, David
A1 Prendergast, Bernard
A1 Norris, Jonathan H
YR 2014
UL http://bjo.bmj.com/content/98/10/1320.abstract
AB The management of antiplatelet and anticoagulant treatment can be challenging for the ophthalmic surgeon with the risk of impaired surgical view or potentially sight-threatening haemorrhage. With the advent of newer medications and the expanding usage of these drugs, there is a need for up-to-date guidance on the subject. This paper describes the current use of modern antiplatelet and anticoagulant drugs in the UK, and reviews the evidence of such treatments in the context of ophthalmic surgery. A multidisciplinary approach has been used to develop a guideline for the management of antiplatelet and anticoagulation treatment in elective ophthalmic surgery. Specifically, guidance is provided on when and how to stop antiplatelet and anticoagulant treatment and, importantly, when to seek specialist medical advice.